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A B S T R A C T
Background: Amyotrophic lateral sclerosis (ALS) is a universally fatal neurodegenerative disease. ALS is deter-
mined by gene-environment interactions and improved understanding of these interactions may lead to
effective personalised medicine. The role of physical exercise in the development of ALS is currently
controversial.
Methods: First, we dissected the exercise-ALS relationship in a series of two-sample Mendelian randomisa-
tion (MR) experiments. Next we tested for enrichment of ALS genetic risk within exercise-associated tran-
scriptome changes. Finally, we applied a validated physical activity questionnaire in a small cohort of
genetically selected ALS patients.
Findings: We present MR evidence supporting a causal relationship between genetic liability to frequent and
strenuous leisure-time exercise and ALS using a liberal instrument (multiplicative random effects IVW,
p=0.01). Transcriptomic analysis revealed that genes with altered expression in response to acute exercise
are enriched with known ALS risk genes (permutation test, p=0.013) including C9ORF72, and with ALS-associ-
ated rare variants of uncertain significance. Questionnaire evidence revealed that age of onset is inversely
proportional to historical physical activity for C9ORF72-ALS (Cox proportional hazards model, Wald test
p=0.007, likelihood ratio test p=0.01, concordance=74%) but not for non-C9ORF72-ALS. Variability in average
physical activity was lower in C9ORF72-ALS compared to both non-C9ORF72-ALS (F-test, p=0.002) and neuro-
logically normal controls (F-test, p=0.049) which is consistent with a homogeneous effect of physical activity
in all C9ORF72-ALS patients.
Interpretation: Our MR approach suggests a positive causal relationship between ALS and physical exercise.
Exercise is likely to cause motor neuron injury only in patients with a risk-genotype. Consistent with this we
have shown that ALS risk genes are activated in response to exercise. In particular, we propose that G4C2-
repeat expansion of C9ORF72 predisposes to exercise-induced ALS.
Funding: We acknowledge support from the Wellcome Trust (JCK, 216596/Z/19/Z), NIHR (PJS, NF-SI-0617-
10077; IS-BRC-1215-20017) and NIH (MPS, CEGS 5P50HG00773504, 1P50HL083800, 1R01HL101388, 1R01-
HL122939, S10OD025212, P30DK116074, and UM1HG009442).








Amyotrophic lateral sclerosis (ALS) is a devastating, rapidly pro-
gressive and relatively common neurodegenerative disease with a
lifetime risk of ~1/400 [1]. ALS is thought to result from interplay
between the environment and risk-genotypes [2]. Like other complex
diseases, the risk of ALS has a significant heritable component [3,4],
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but the penetrance of specific genetic variants is variable which is
consistent with environmental modifiers. ALS is notable for the late
age of onset, even in rare monogenic forms, and this has been inter-
preted as a ‘multiple-hit’ process involving sequential genetic and
environmental insults [5,6]. Identification of specific gene-environ-
ment interactions may open the door to personalised medicine and
even disease prevention.
To date, identification of environmental risk factors for ALS has
been limited. ALS has a higher incidence and lower age of onset in
professional sportspeople which led to the proposal that exercise is a
risk factor for ALS [7]. However, epidemiological studies attempting
to quantify exercise-history in ALS patients have produced conflicting
results [8-11]. These studies have largely relied on questionnaire-
based quantification of exercise in an unselected cohort of ALS
patients. Inherent in these approaches is selection bias, recall bias,
and confounding due to the effect of exercise on other causes of mor-
tality. In particular, failure to consider genetic heterogeneity within
ALS cohorts may have masked specific gene-environment interac-
tions. Of the conflicting results that have been published, it is poten-
tially significant that a positive relationship between ALS risk and
exercise has often been reported in populations with high incidence
of the G4C2 repeat expansion within C9ORF72 [9,12,13]. C9ORF72
expansion is the most common genetic risk factor for ALS, but shows
marked phenotypic variability including incomplete penetrance [14].
This variability has led to the proposal of various genetic and environ-
mental modifiers, but to date no specific modifier has been conclu-
sively demonstrated.
Exercise itself is a heterogeneous activity. Muscle fibres and motor
neurons are sub-specialised for aerobic and anaerobic conditions.
Skeletal muscle fibres are categorised as fast twitch (type IIa, IIb and
IIx) or slow-twitch (type I) according to functional (e.g. contractile
speed) and metabolic properties [15]. In ALS it is the motor neurons
supplying type IIb muscle fibres responsible for anaerobic burst activ-
ity which are most vulnerable to the disease process [16,17]. On this
basis we propose that ALS may be associated specifically with vigor-
ous exercise and indeed this hypothesis is consistent with several
previous studies [9,18]. In designing the present study we therefore
focused on frequent and intense, anaerobic, burst activity often
undertaken in leisure, training and competitive physical exercise
activities [19].
Two-sample Mendelian randomisation (MR) allows evaluation of
the relationship between an exposure and an outcome through
upstream genetic correlates in independent cohorts. Genetic corre-
lates are measured in a genome-wide association study (GWAS). This
ameliorates much of the bias which has confounded previous studies
of historical-exercise in ALS patients. We set out to use MR to test
whether physical exercise is a risk factor for the development of ALS.
We hypothesised that some of the inconsistency between previous
studies may reflect heterogeneity in exercise measures and we there-
fore focused on GWAS measuring frequent and strenuous leisure-
time activity. To address genetic heterogeneity we evaluated the
association between exercise-associated gene expression changes
and ALS risk, and we have evaluated historical physical activity in a
small cohort of genetically homogeneous ALS patients. Our study
approach is summarised in Fig. 1.
2. Methods
2.1. Two-sample Mendelian randomisation (MR)
2.1.1. Objective
In MR, SNPs associated with an exposure of interest are used as
instrumental variables (IV) to explore the causal relationship
between that exposure and an outcome of interest. According to
Mendel's laws of segregation and independent assortment, this
methodology can be considered a natural experiment in which
Research in context
Evidence before this study
The role of physical activity as a risk factor for ALS was evaluated in
a systematic review of 26 studies performed by Lacorte et al. in
2016. The authors concluded that there was insufficient evidence
to draw a firm conclusion and highlighted limitations of previous
studies relating to heterogeneous classification of both physical
activity and ALS. They noted that none of the published literature
achieved the highest quality rating in the Newcastle Ottawa Scale,
which they attribute to methodological challenges posed by the
rarity and severity of the disease. To identify more recent publica-
tions, we conducted a literature search using the PubMed database
for articles published between 01/01/2015 - 11/11/2020. The
search terms used were ("Amyotrophic lateral sclerosis"[Title/
Abstract] OR "motor neuron disease"[Title/Abstract] ORMND[Title/
Abstract] OR ALS[Title/Abstract]) AND (PA[Title/Abstract] OR exer-
cise[Title/Abstract] OR "physical activity"[Title/Abstract] OR sport
[Title/Abstract]). This search strategy yielded 182 results which we
filtered for original, observational, human-subject studies; we also
excluded case series with <10 participants and case reports. This
process identified 12 further relevant publications which reported
contrasting conclusions without significantly addressing the meth-
odological issues highlighted above. A single recent study used
linkage disequilibrium score regression andMendelian randomisa-
tion to test for a causal relationship between ALS and a number of
UK biobank questionnaire items including participation in light
DIY, walking for pleasure and moderate activity duration, but this
study did not address the relationship between ALS and physical
exercise which is both frequent and strenuous. This study con-
cluded that there was a correlation between genetic liability to
physical exercise and ALS but they did not record a positive MR
result to indicate causation.
Added value of this study
In the present study, we have exploited themethodological advan-
tages of Mendelian randomisation (MR) to counter bias, together
with a tailored approach to physical activity exposure aimed at iso-
lating exercise which is both frequent and strenuous. We achieved
this by selecting and combining UK biobank questionnaire items.
We present the firstMR evidence of physical exercise as a causative
factor in the development of ALS. Furthermore, we have addressed
the gene-environment interaction by measuring the effect of exer-
cise on expression of ALS risk genes. Finally, we have considered in
detail the relationship between physical activity and the most fre-
quent genetic risk factor for ALS: hexanucleotide (G4C2) repeat
expansion of C9ORF72. Our data suggest that genetic liability to lei-
sure time physical activity is a risk factor for ALS and C9ORF72-ALS
in particular. In addition, we offer evidence that a number of
known ALS-associated genetic variants are functionally linked to
the physiological response to exercise.
Implications of all the available evidence
Our results indicate that participation in frequent and strenuous
leisure time physical activity is a risk factor for ALS, particularly in
the context of certain risk genotypes. This could explain some of
the controversy in previous studies which have largely neglected
genetic heterogeneity within ALS patients. Our results form a plat-
form for future research to explore the interaction between specific
genotypes and exercise-induced ALS in a prospective manner with
larger numbers, and in selected pedigrees. Ultimately this could
lead to the design of a personalised medicine approach including
lifestyle advice regarding physical activity, to patients with ALS and
their familymembers.
2 T.H. Julian et al. / EBioMedicine 68 (2021) 103397
individuals are at conception randomly assigned to groups with dif-
fering levels of genetic liability to an exposure of interest. A core
strength of MR is the ability to remove unmeasured confounding and
to differentiate between a shared genetic basis for the exposure and
outcome (known as genetic pleiotropy), and potential causation. By
utilising SNPs associated with various forms of exercise, we are there-
fore able to interrogate the relationship between exercise and ALS.
SNPs which make up the IV are usually selected on the basis of
genome wide association studies (GWAS) used to assess the signifi-
cance of the relationship between specific genetic variants and an
exposure of interest [20].
2.1.2. Study participants
In this study, the instrumental variables (IV) were derived from
publicly available GWAS data. None of the exposure GWAS partici-
pants overlapped with those in the ALS outcome GWAS which is
important to avoid bias.
SSOE was measured via questionnaire in UK Biobank (UKB) partic-
ipants [21]. Individuals completing the physical activity question-
naire were also asked “In the last 4 weeks did you spend any time
doing the following?” with the potential answers were: ‘walking for
pleasure’, ‘other exercises’, ‘strenuous sports’, ‘light DIY’, ‘heavy DIY’,
‘none of the above’, and ‘prefer not to answer’. To address the ques-
tion of which SNPs were associated with frequent participation in
“strenuous sports” and “other exercise” (SSOE) the responses were
dichotomised to compare those who reported spending two-three
days per week or more performing SSOE for a duration of 15-30
minutes or greater, with those and who did not report spending any
time within the last four weeks performing SSOE. A total of 124,842
cases and 225,650 controls contributed to the SSOE GWAS. The data
were analysed with a linear mixed model. The UKB data field referen-
ces for the questions used to create this GWAS are 6164, 3647, 1001,
3637 and 991.
We carried out a number of sensitivity analyses to check whether
association with ALS was specific to frequency and strenuous physi-
cal exercise. We evaluated the relationship between ALS and partici-
pation in strenuous sport during the last 4 weeks with no minimum
threshold for frequency or duration [22]; and heavy DIY which was
excluded from the SSOE measure [22]. These GWAS also utilised the
UKB questionnaire; they included 460,376 subjects and analysis was
performed using a linear mixed model. To quantify movement inde-
pendent of exercise we utilised accelerometer data: UKB subjects
wore an Axivity AX3 accelerometer for one week, a linear mixed
model GWAS analysis was conducted on the basis of three measures:
1) overall average acceleration; 2) fraction of accelerations > 425
milligravities; 3) sedentary behaviour [21,23]. 91,084 individuals
data contributed to the average accelerations analysis, 90,667 to the
GWAS of fraction of accelerations >425 milligravities and 91,105 to
the GWAS of sedentary behaviour [23].
Body fat was measured by dual energy x-ray absorptiometry or
bioimpedance analysis [24]. Body fat GWAS was performed as a
meta-analysis and included 100,716 individuals.
Educational attainment was quantified as years of education mea-
sured at an age of at least 30 years; GWAS was performed in a meta-
analysis of 1,131,881 individuals [25].
ALS GWAS was performed utilising a linear mixed model as previ-
ously described [26]. This is the largest published ALS GWAS to date
where a linear mixed model (LMM) was used to correct for popula-
tion differences [27]; this GWAS included 12,577 cases and 23,475
controls from 41 cohorts. It has been previously demonstrated that a
LMM can achieve improved power over a meta-analysis without sig-
nificant false positives [26].
Limitations of GWAS datasets are discussed in the Supplementary
Note.
2.1.3. Selection of exposure instrumental variables (IV)
Exposure IV are chosen based on an arbitrary p-value cut off
[28,29]. A cut-off which is too low will lose informative instruments,
but a cut-off which is too high could introduce non-informative
instruments. We chose to utilise a positive control to determine the
optimum number of IV to measure SSOE; this is independently sup-
ported best practice [20]. Body fat percentage was chosen as a posi-
tive control because there is a clear and described biological
mechanism linking increased exercise to reduced body fat. We com-
pared a liberal (p<1E-06) and conservative (p<5E-08) instrument to
test the relationship between SSOE and body fat percentage; both
results were significant but the liberal instrument had a greater
power. Moreover, certain of the robust analyses using the
Fig. 1. Exercise is a risk factor for amyotrophic lateral sclerosis: Convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. A graphical abstract
describing the fundamental elements of the study and core results. ALS = amyotrophic lateral sclerosis; PA = physical activity; SNP = single nucleotide polymorphism;
GWAS = genome wide association study.
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conservative instrument paradoxically suggested that increased
physical exercise should increase body fat percentage (Table 2, Sup-
plementary Table 8). We note that others have concluded that a con-
servative instrument is an underpowered measure of SSOE [28].
Consequently, we have used a liberal instrument to measure SSOE in
our analysis.
Identified SNPs at each significance threshold were clumped for
independence using PLINK clumping in the TwoSampleMR tool [30].
A stringent cut-off of R2  0.001 and a window of 10,000kb was used
for clumping within a European reference panel. Where SNPs were in
linkage disequilibrium (LD), those with the lowest p-value were
retained. SNPs which were not present in the reference panel were
excluded. Where an exposure SNP was unavailable in the outcome
dataset, a proxy with a high degree of LD (R2  0.9) was identified in
LDLink within a European reference population [31]. Where a proxy
was identified to be present in both datasets, the target SNP was
replaced with the proxy in both exposure and outcome datasets in
order to avoid phasing issues [32]. Where a SNP was not present in
both datasets and no SNP was available in sufficient LD, the SNP was
excluded from the analysis. All SNPs selected for inclusion in this study
are presented in the supplementary data in order to allow replication.
2.1.4. Exposure-outcome instrument harmonisation
The effects of SNPs on outcomes and exposures were harmonised
in order to ensure that the beta values were signed with respect to
the same alleles. For palindromic alleles, those with minor allele fre-
quency (MAF) > 0.42 were omitted from the analysis in order to
reduce the risk of errors due to strand issues [32].
2.1.5. Assumptions and robust analyses
The MR measure with the greatest power is the inverse-variance
weighted (IVW) method, but this is contingent upon the exposure IV
assumptions being satisfied [33]. With the inclusion of a large num-
ber of SNPs within the exposure IV, it is possible that not all variants
included are valid instruments and therefore, in the event of a signifi-
cant result, it is necessary to include a range of robust methods which
provide valid results under various violations of MR principles at the
expense of power [20]. Robust methods applied in this study include
MR-Egger, MR-PRESSO, weighted median, weighted mode and the
robust adjusted profile score (RAPS).
With respect to the IVW analysis, a fixed-effects (FE) model is
indicated in the case of homogeneous data, whilst a multiplicative
random effects (MRE) model is more suitable for heterogeneous data.
Burgess et al recommend that an MRE model is implemented when
using GWAS summary data to account for heterogeneity in variant-
specific causal estimates [20]. In the interest of transparency, we cal-
culated both results but present the MRE in the text.
MR analyses should include evaluation of exposure IV strength. In
order to achieve this, we provide the F-statistic, MR-Egger intercept,
MR-PRESSO global test, Cochran's Q test and I2 for our data. The F-sta-
tistic is a measure of instrument strength with >10 indicating a suffi-
ciently strong instrument [34]. We provide F-statistics for individual
exposure SNPs and the instrument as a whole. Cochran's Q test is an
indicator of heterogeneity in the exposure dataset and serves as a
useful indicator that horizontal pleiotropy is present as well as direct-
ing decisions to implement FE or MRE IVW approaches [35]. The MR-
Egger intercept test determines whether there is directional horizon-
tal pleiotropy. The MR-PRESSO global test determines if there are sta-
tistically significant outliers within the exposure-outcome analysis
[36]. I2 was calculated as a measure of heterogeneity between variant
specific causal estimates, with a low I2 indicating that Egger is more
likely to be biased towards the null [37]. Finally, we performed a
leave-one-out analysis using the method of best fit for each
exposure SNP within the IV in order to determine if any single var-
iants were exerting a disproportionate effect upon the results of our
analysis [20].
2.2. Linkage disequilibrium score regression (LDSC)
2.2.1. Objective
LDSC is a tool which can be utilised in order to evaluate genetic
correlation between traits using GWAS summary statistics. This
method does not however distinguish between genetic correlation
(pleiotropy) and causation.
2.2.2. Study participants
The aforementioned SSOE and ALS GWAS data were utilised in
LDSC.
2.2.3. Analysis
For the most part, we did not deviate from the default settings
recommended by authors of the LDSC package [38,39]. SNPs were fil-
tered according to presence in HapMap3, MAF > 0.01, removal of
strand ambiguous SNPs and duplicated SNPs. In our analysis we offer
both a regression estimate without constraining the heritability esti-
mates of ALS and SSOE and with a constrained ALS intercept as rec-
ommended previously [40].
2.3. Burden testing
Whilst GWAS is useful for exploring the genetic architecture of
disease, this methodology does not capture low-frequency or rare
variation [41] which is key to the genetic architecture of ALS [26].
Rare variants are addressed by rare variant burden testing [42]. In
this study, we grouped genes within pathways which changed
expression in response to exercise. We measured the rate of observed
rare mutations within exercise pathways in ALS patients compared to
controls. By identifying ALS-associated genetic variation within path-
ways functionally related to acute exercise, we aimed to implicate
specific genotypes in motor neuron vulnerability to PA.
Burden testing was performed using whole genome sequencing
data from 4,425 ALS patients and 1,925 controls [43]. We have previ-
ously identified genes and pathways differentially expressed in
response to exercise [44]. In brief 36 subjects underwent symptom-
limited cardiopulmonary exercise (CPX) testing with whole tran-
scriptome profiling by sequencing of RNA extracted from peripheral
blood mononuclear cells at 2, 15, 30 and 60 minutes post exercise
[44]. For the purpose of the present research, pathways which were
differentially expressed at the most immediate time point of 2
minutes post-CPX testing (p<0.001) were selected for burden testing.
For each pathway we calculated the proportion of genes which were
significantly enriched with rare (MAF<1%) ALS-associated mutations
which alter amino-acid sequence [43]. To determine significant
enrichment of each pathway with ALS-associated mutations we cal-
culated the equivalent enrichment within 5,000-30,000 random gene
sets of equivalent length. Reported p- and FDR values for pathway
enrichment refer to the proportion of random gene sets with equiva-
lent enrichment. To ensure stable p-value estimates the number
of random gene sets was increased such that 3 random sets were
discovered with equivalent enrichment to each pathway under con-
sideration.
2.4. Expression of ALS-related genes during exercise
In order to determine whether ALS-related genes are differentially
expressed during physical exercise, we measured expression changes
of known ALS genes post-exercise [44]. We utilised a clinical ALS
gene panel (Next Generation Sequencing at Sheffield NHS Children's
Hospital, Supplementary Table 9) [45]. The proportion of ALS genes
which were differentially expressed with exercise was compared to a
1,000 random gene sets of the same length.
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2.5. A C9ORF72-specific case-control study of historical PA
2.5.1. Study participants
ALS cases were identified by a Consultant Neurologist according to
revised El-Escorial criteria. Cases with family history or other clinical
features consistent with C9ORF72-disease such as young age of onset
or extra-motor features underwent genetic testing for the G4C2-
expansion. Inclusion criteria for the study were as follows: (1) Con-
firmed C9ORF72 pathological G4C2-repeat expansion; (2) patients
were over 18 years of age whose disease manifested in adult life; and
(3) diagnosis had taken place within the last two years. Exclusion cri-
teria were as follows: (1) patients with concurrent neurological dis-
ease; (2) patients with symptoms incompatible with completing the
HAPAQ questionnaire such as overt cognitive impairment. Participa-
tion was maximised by travelling to administer the questionnaire in
the patient's place of residence; in this way we managed to avoid any
failed recruitment and consequent selection bias.
Two control groups were used in this study: those with ALS but
without the C9ORF72 G4C2-expansion, and neurologically normal
controls. Both groups were matched to C9ORF72-ALS patients for age
and gender. Control data were obtained from a previous study [9].
Participants in the study are summarised in Table 4.
2.5.2. Measurement of physical activity
Physical activity was measured using the HAPAQ questionnaire
which has been previously validated for the determination of histori-
cal PA [46]. Briefly a life calendar was used to orientate participants
and aid recall. The questionnaire is structured by time period, of
which two broad lengths of time are covered (a) the most recent
15 years, split into three 5-year categories and (b) the whole of adult-
hood, by decade, starting from the age of 20 years. In each discrete
time period a series of questions are asked about physical activity
within four distinct domains: (a) in and around the home; (b) at
work or commuting to work; (c) physical activity that makes you out
of breath/sweat and (d) physical activity that does not make you out
of breath or sweat. For each domain, closed questions are asked about
the type, duration, and frequency of the PA.
2.5.3. Statistical analysis
Every unique activity was assigned a MET value according to the
Compendium of Physical Activities [47]. Based on these values we
calculated a measure of the average daily physical activity in kJ/kg/
day for each patient during each time period which accounted for
type, duration, intensity, and frequency of PA. To compare between
subjects an overall average daily physical activity value was calcu-
lated for the most recent 20 years excluding the most recent 5 years
which may have been confounded by subclinical symptom onset.
2.6. Software
The TwoSampleMR (version 0.5.5) package in R (version 4.0.2)
was used to perform Mendelian randomisation [48]. Proxy SNPs for
Mendelian randomisation were identified using the LDLinkR (version
1.0.2) package [49]. The code which we utilised for the more statisti-
cally complex aspects of the work (MR and burden analysis) is pro-
vided in the Supplementary Note. R language was also utilised for
burden testing and various basic calculations, performed using base
R and dplyr functionality. The statistics program STATA/IC (version
15.0) was used for statistical analysis of case-control data. The LDSC
(version 1.0.1) package was operated using Anaconda Python (ver-
sion 3.8) in order to produce LD score regression estimates.
2.7. Ethics
Relevant National Health Service (NHS) and university research
ethical approvals were obtained (IRAS189432 / STH19120) and pro-
cedures followed were in accordance with these standards. All study
participants provided informed consent.
2.8. Role of funding source
Funders had no role in study design, data collection, data analyses,
interpretation, or writing of the manuscript.
3. Results
3.1. Genetic liability to frequent, strenuous, leisure-time exercise is a risk
factor for ALS
We hypothesised that genetic liability to exercise is associated
with ALS. Exercise is not a single exposure, but is heterogeneous both
in terms of the activity performed and the metabolic, neuromuscular
and cardiovascular consequences. Our previous work has indicated
that leisure-time strenuous activity may be linked to risk of ALS [9];
this is captured by a ‘strenuous sport and other exercise’ (SSOE)
GWAS (Methods) [21]. Importantly this measure includes thresholds
for both intensity and frequency of physical activity: 2-3 days per
week or more performing SSOE for a duration of 15-30 minutes or
greater. Interestingly, occupational physical activity is negatively
associated with the SSOE measure, suggesting that SSOE is a rela-
tively specific measure of frequent and intense leisure-time activity
[21]. As controls we have employed GWAS of (i) strenuous sport with
a lower frequency threshold: performed at any time during the last 4
weeks; (ii) heavy DIY; and (iii) an accelerometer study of total move-
ment over a limited period (Methods).
We discovered that genetic liability to SSOE is positively associ-
ated with ALS using a liberal instrument (IVW p=0.01, beta=0.21,
Table 1, Fig. 2, Supplementary Table 1). Use of a liberal instrument
Table 1
Two-sample Mendelian randomisation demonstrates that strenuous sport and other exercise (SSOE) is a risk factor for ALS using a
liberal instrument.
Instrument Mendelian randomisation method Beta Standard error p value
Liberal (p<1E-06) Inverse variance weighted (fixed effects) 0.21 0.08 0.007
Inverse variance weighted (multiplicative random effects) 0.21 0.08 0.01
MR Egger 0.75 0.41 0.07
Weighted median 0.22 0.11 0.05
Weighted mode 0.52 0.25 0.04
MR RAPS with overdispersion model 0.21 0.09 0.009
MR RAPS without overdispersion model 0.24 0.08 0.005
Conservative (p<5E-08) Inverse variance weighted (fixed effects) 0.28 0.16 0.07
Inverse variance weighted (multiplicative random effects) 0.28 0.18 0.11
MR Egger -1.09 0.89 0.26
Weighted median 0.17 0.22 0.44
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is supported by analysis of a positive control where we compared a
liberal and a conservative instrument to measure the effect of SSOE
on body fat percentage (Methods, Table 2). There was no statistically
significant heterogeneity or directional pleiotropy and the F-statistic
indicates adequate instrument strength (Table 3). MR-PRESSO global
test and leave-one-out analysis did not demonstrate any SNP outliers
(Table 3). Robust tests consistently reached or were close to signifi-
cance (Table 1). This result is consistent with a causative relationship
between frequent and strenuous exercise, and ALS which is not con-
founded by selection or recall bias. This result suggests that the asso-
ciation is driven primarily by a deleterious effect of exercise on
motor neuron health and not by horizontal pleiotropy, i.e. our data
are not consistent with a common genotype which independently
influences both exercise and ALS (Methods).
Movement alone was not significantly associated with ALS, which
is consistent with our hypothesis that ALS is linked to strenuous exer-
cise. MR determined a non-significant association with ALS for frac-
tion of accelerations >425 milligravities (IVW, p=0.13, beta=-0.11,
Supplementary Table 2, Supplementary Fig. 1) and average
accelerations (IVW, p=0.31, beta=-0.005, Supplementary Table 3,
Supplementary Figure 2). Moreover, neither infrequent ‘strenu-
ous sport’ (IVW, p=0.13, beta=0.35, Supplementary Table 4,
Fig. 2. Genetic liability to frequent, strenuous, leisure-time exercise is a risk factor for ALS.
(a) Scatter plot demonstrating the positive correlation between genetic liability to strenuous sport and other exercise (SSOE) and ALS, as measured with a liberal instrument.
Points indicate effect size (b) and standard errors for each SNP-outcome relationship (i.e. ALS and SSOE). The relationship is not significantly altered by removal of any single SNP.
The weighted median estimator is not significantly different to the IVW (b = 0.22 and 0.21 respectively) and therefore cannot be independently visualised. (b) A symmetrical funnel
plot (vertical line of best fit) demonstrates that SNP effect size (b) is not correlated with SNP precision i.e. inaccurate instruments are not overvalued which could lead to directional
pleiotropy. (c) Forest plot illustrates that the effect of SSOE on ALS is consistent whether measured by individual SNPs or by MR Egger (upper red line) or IVW (lower red line). The
overlapping confidence intervals of each causal estimate show there is no significant heterogeneity.
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Supplementary Figure 3) or heavy DIY (IVW p=0.17, beta=-0.17,
Supplementary Table 5, Supplementary Figure 4) were signifi-
cantly associated with ALS. Overall, our data are consistent with
the hypothesis that risk of ALS is linked to frequent and intense
leisure-time physical activity.
Linkage disequilibrium score regression (LDSC) is a technique to
determine whether two traits share a common genetic architecture.
Unlike MR, LDSC cannot distinguish a causal relationship between
exposure and outcome from pleiotropy. Consistent with our MR
result, a LDSC analysis revealed a positive genetic correlation
between ALS and SSOE (r=0.17, standard error=0.09, Supplementary
Table 6) which was borderline statistically significant (p=0.06). In a
previous analysis using the same ALS GWAS data, the authors con-
strained the intercept for heritability of ALS to 1 on the basis that
population structure and confounding were carefully controlled in
the ALS GWAS [40]. If we employ the same strategy then the correla-
tion between SSOE and ALS becomes statistically significant (r=0.08,
standard error=0.04, p=0.04, Supplementary Table 6).
3.2. Sedentary behaviour is not significantly associated with ALS
We argued that if strenuous exercise is a risk factor for ALS, then
sedentary behaviour may be protective. However, our MR study does
not support this conclusion. Sedentary behaviour is not significantly
related to ALS (IVW p=0.29, beta=-0.04, Supplementary Table 7, Sup-
plementary Figure 5).
3.3. Association between physical exercise and ALS is not mediated by
body fat percentage
Body fat percentage has previously been described as a potential
risk factor for ALS [50]. If true this would represent a possible source
of pleiotropy or confounding in the SSOE-ALS relationship. However,
our analysis demonstrates that body fat percentage is not signifi-
cantly associated with ALS (IVW, p=0.43, beta=-0.03, Supplementary
Table 9, Supplementary Figure 6) and is therefore unrelated to the
pathophysiological impact of SSOE. This finding is in keeping with a
previous MR which concluded that there is no causal relationship
between BMI and ALS [51].
3.4. Association between exercise and ALS is not mediated by
educational attainment
The relationship between years of education and ALS was mea-
sured to identify whether this variable might have been a confounder
for the SSOE-ALS relationship. Previous studies have demonstrated
that leisure-time SSOE is positively correlated with educational
attainment suggesting that our result could be confounded by a link
between lower educational attainment and increased risk of ALS
[21]. Due to the large number of SNPs identified at genome-wide sig-
nificance which were eligible for analysis (n=298), only a conserva-
tive instrument was used. This demonstrated no significant
relationship between ALS and educational attainment (IVW p=0.64,
beta=-0.01, Supplementary Table 10, Supplementary Figure 7).
3.5. Exercise-induced pathways are enriched with ALS genetic risk
Our results suggest that physical exercise is a risk factor for ALS.
We set out to identify risk genotypes for exercise-induced ALS using
transcriptomics. We hypothesised that risk genes for exercised-
induced ALS should be differentially expressed in response to exer-
cise. This could provide a functional link whereby exercise amplifies
toxicity resulting from a genetic mutation. We measured gene
expression changes in peripheral blood mononuclear cells (PBMCs)
in response to exercise and identified 323 biological pathways that
are differentially expressed in response to acute exercise including
‘ALS signaling’ [44]. We tested for enrichment of ALS genetic risk
within each of these pathways by rare variant burden testing utilising
whole-genome sequencing (WGS) data from 4,495 sporadic ALS
patients and 1,925 controls (Methods and [43]). Our focus on rare
variants was guided by previous work demonstrating that ALS has a
polygenic rare variant architecture [26]. Strikingly 72 pathways (22%)
are significantly enriched with ALS-associated rare deleterious var-
iants after multiple testing correction (FDR<0.05, Fig. 3a, Supplemen-
tary table 11) including the ‘ALS signaling’ pathway (p=0.0007). One
pathway was significantly enriched with ALS-associated rare variants
even after a stringent Bonferroni multiple testing correction: fibroblast
growth factor (FGF) signaling (p=0.0001, Fig. 3a-b). Nerve growth factor
(NGF) signaling is closely related to FGF signaling and is also highly
enrichedwith ALS-associated rare variants (p=0.0002, Fig. 3a-b).
We hypothesised that, if exercise-induced gene expression changes
are enriched with ALS risk, then known ALS genes should also be dif-
ferentially expressed following exercise [44]. Consistent with our
hypothesis 52% of clinically validated ALS-related genes are differen-
tially expressed following acute exercise and this enrichment is statis-
tically significant (permutation test, p=0.013, Fig. 3c, Supplementary
Table 12, Methods). The list of differentially expressed genes included
down-regulation of C9ORF72 (fold change=-0.2, FDR=0.0002).
3.6. Case-control study of C9ORF72-ALS suggests that exercise is a
disease modifier
To investigate the possible gene-environment interaction further,
we studied historical physical activity using the validated HAPAQ
Table 2
Positive control two-sample Mendelian randomisation analysis of the relationship between strenuous sport and other exercise (SSOE), and body fat percentage. This analysis
was used to chose the best instrument for analysis of the relationship between SSOE and ALS. The liberal instrument appears to produce more precise estimates with smaller
standard errors and greater power, due to the larger number of SNPs. Although MR RAPS is significant in both the liberal and conservative analysis, the conservative tool para-
doxically identifies a positive relationship between SSOE and body fat percentage.
















Conservative (p<5E-08) -0.78 0.003 0.01 0.23 0.97 0.37 (falsely positive beta) 0.04 (falsely positive beta)
Liberal (p<1E-06) -0.64 0.000004 0.00002 0.03 0.85 0.64 0.0004 (correctly identified
negative beta)
Table 3
Two-sample Mendelian randomisation for the effect of strenuous sport and other
exercise (SSOE) on risk of ALS consists of robust instrumental variables.
Statistical test Salient results
Cochran's Q (for IVW) p=0.31
MR-Egger intercept p=0.18
Leave-one-out with fixed effects IVW P=0.003-0.02 with a consistently
positive beta.
I2 test 0.96
F statistic for the combined
instrument
28.15
MR-PRESSO global test p=0.33
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questionnaire [46] in a cohort of C9ORF72-ALS patients (n=17) com-
pared to age and sex matched non-C9ORF72-ALS patients (n=34) and
neurologically normal controls (n=34) (Table 4). We proposed that
variable disease penetrance in carriers of a G4C2-repeat expansion of
C9ORF72 is in part due to differences in exercise history. In our model,
an individual carrying a C9ORF72 expansion is likely to develop ALS
when they receive a certain ‘dose’ of exercise. Consistent with our
model, age of ALS onset was negatively correlated with average daily
Fig. 3. Exercise-induced pathways are enriched with ALS genetic risk.
(a) Transcriptome analysis of peripheral blood mononuclear cells (PBMCs) reveals that biological pathways differentially expressed following acute exercise are significantly
enriched with ALS-associated rare variants. The pathways depicted pass multiple testing correction (FDR<0.05). (b) Differentially expressed biological pathways are closely related
to neuronal health. Broadly, the roles of fibroblast growth factor (FGF) and nerve growth factor (NGF) pathways are cell proliferation, apoptosis and cell survival, cell differentiation
and cell migration. The NGF and FGF pathways are significantly related to ALS and are enriched following acute exercise. In ALS, it is possible that mutation in these pathways leads
to deranged differential expression in response to hypoxia, oxidative stress and starvation during exercise and this may precipitate damage to motor neurons. (c) ALS risk genes
which are differentially expressed in response to exercise are shown with fold change and significance.
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physical activity in C9ORF72-ALS patients (Cox proportional hazards
model, Wald test p=0.007; likelihood ratio test, p=0.01; con-
cordance=74%; hazards ratio i.e. reduction in age of onset per 1kJ/kg/
day change in exercise=1.03 years, with 95% confidence interval
1.009-1.06 years; Fig. 4a). The same was not true for non-C9ORF72-
ALS patients (Cox proportional hazards model, Wald test p=0.1; likeli-
hood ratio test, p=0.1; concordance=62%; hazards ratio=1.005, with
95% confidence interval 0.9987-1.012 years). After correcting for
group size, variability in average physical activity was lower in
C9ORF72-ALS compared to both non-C9ORF72-ALS (F-test, p=0.002;
Fig. 4b) and neurologically normal controls (F-test, p=0.049; Fig. 4b).
Reduced variability is consistent with our model because it suggests
a homogeneous effect of physical activity in all C9ORF72-ALS patients.
Our data do not exclude a role for physical activity in non-C9ORF72-
ALS, but the increased heterogeneity in this group suggests that the
effect size is variable.
4. Discussion
ALS is an archetypal complex disease determined by interaction
between genetic risk factors and environmental modifiers [2]. Consis-
tent with this, the incidence of ALS varies between populations [52]
and is lowest when ancestry is relatively mixed [53]. Understanding
gene-environment interactions which increase the risk of ALS will
lead to new personalised medicine approaches. For rare forms of ALS
which are purely genetically determined, this is already a reality [54].
It is likely that the search for environmental risk factors has been hin-
dered by studies which have failed to account for heterogeneity in
both environmental exposures and ALS genetic subtypes: specific
exposures are likely to be relevant only in the presence of specific
genotypes. We have used two-sample MR to establish the basis for
frequent and strenuous leisure-time exercise as a risk factor for ALS
and we have also developed understanding of the specific genetic
subtypes of ALS which may be responsible for this interaction.
The link between exercise and ALS risk has previously been con-
troversial [8,9]. The advantage of a two-sample MR methodology is
that it can avoid much of the bias and confounding factors which
have hindered previous analyses. It should be noted that not all of
our robust analyses were statistically significant however these tests
are relatively underpowered [55], and our sensitivity analyses do not
provide any evidence of significant instrument heterogeneity or
directional pleiotropy to suggest that the IVW result is invalid.
Exercise is not one homogeneous exposure; in reality different
types of exercise can impact different biological pathways and even
different subtypes of motor neurons. Early in the disease process ALS
is known to selectively affect motor neurons supplying type IIb fast
twitch muscle fibres important for high intensity anaerobic exercise
[16,17]. Consistent with this, our MR study does not support a causal
role for low-intensity, infrequent exercise, but does support toxicity
resulting from high-intensity, frequent, leisure-time exercise. The
SSOE measure of exercise we utilised is negatively correlated with
occupational activity suggesting that it is a specific measure of stren-
uous leisure-time activity [21]. Variations in the cardiovascular
impact of occupational and leisure time activity are thought to repre-
sent more static occupational activity versus more dynamic leisure-
time activity [19,56]. This suggests that intense leisure-time physical
exercise is more likely to include strenuous anaerobic activity and
might explain why this type of physical activity shows a strong asso-
ciation with ALS. Similarly our data show that static activity such as
heavy DIY, is not associated with ALS.
Physical exercise is causally linked to several factors which may
modify the risk of ALS including body fat percentage [50], educational
attainment [11], cigarette smoking [57], type 2 diabetes mellitus [58],
and head trauma [59], and each of these is a potential confounder;
although we note that a recent MR study has disputed the causal rela-
tionship with smoking [60]. We are confident that the effect we
observe is a direct effect of exercise and not an indirect effect via one
or more of these factors. Firstly our MR study has demonstrated a
dose-dependent relationship between SSOE and ALS risk [61]. It is
difficult to explain this via an indirect effect which is more likely to
be non-linear. Secondly our MR data do not support a causal relation-
ship between body fat percentage and ALS suggesting that this is not
in reality a potential confounder. Thirdly, increased physical exercise
is associated with increased educational attainment [21], reduced
cigarette smoking [62], and lower risk of type 2 diabetes [63], which
should therefore reduce risk of ALS [11,57,58] in individuals who
exercise more. This is the opposite direction of effect to that which
we observed, and therefore these factors are unlikely to be a source
of confounding. Finally, although risk of head trauma is linked to
physical exercise, the SSOE measure we utilised gives equal weight-
ing for heterogenous activities including some with minimal risk of
head trauma (e.g. aerobics). We propose therefore that head trauma
is unlikely to be a significant confounder of our data.
We discovered that ALS risk genes are differentially expressed fol-
lowing exercise and similarly, a significant number of exercise-
induced biological pathways are enriched with ALS genetic risk. This
provides a functional link between exercise and the activity of ALS
risk genes. Many of these pathways have previously been linked to
neurotoxicity, but our work places them upstream in the pathogene-
sis of exercise-induced ALS. Most prominently, genes linked to fibro-
blast growth factor (FGF) and nerve growth factor (NGF) signaling
were highly enriched with ALS-associated rare variants. FGF1 is
known to induce NGF expression in astrocytes and therefore these
represent related pathways [64]. FGFs are highly expressed in motor
neurons and FGF1 secretion can be stimulated by oxidative stress,
hypoxia and serum starvation [64]. Produced by astrocytes, both NGF
and FGF have been shown to cause motor neuron apoptosis under
specific conditions in vitro and this signaling has been implicated in
ALS pathophysiology [64,65]. A gap in our analysis is the link
between gene expression changes in blood, and toxicity within the
CNS. One possibility is that the two are linked by the mobilisation of
energy stores to facilitate brain metabolism. NGF signaling has been
implicated in glucose-stimulated insulin secretion [66] which is
essential for CNS neurons. A recent 18F-FDG-PET study identified
changes in brain metabolism induced by exercise which overlapped
with changes previously observed in ALS [67]. Interestingly ALS-asso-
ciated changes in brain metabolism were less extensive in patients
with a significant exercise history, at the same stage of disease pro-
gression. The authors proposed that this may represent an exercise-
induced failure of metabolic reserve leading to neurodegeneration.
We suggest that the pathways and genes we have highlighted,
should be explored in detail to define a risk genotype for exercise-
induced ALS. G4C2-repeat expansion of C9ORF72 is the most common
genetic risk factor for ALS, but the phenotype is variable and pene-
trance is incomplete suggesting a role for environmental modifiers
[14]. We hypothesised that exercise may modify the penetrance of
Table 4




Number in group 17 34 34
Proportion male (%) 58.8 58.8 52.9
Age (years) 56.4 (36-71) 57 (35-72) 57 (36-74)
ALS (%) 15 (88.2) 34 (100) -
PMA (%) 2 (11.8) 0 -
PLS (%) 0 0 -
Limb onset (%) 10 (59) 21 (62) -
Bulbar onset (%) 7 (41) 13 (38) -
ALS = amyotrophic lateral sclerosis; PMA= progressive muscular atrophy variant;
PLS= primary lateral sclerosis variant.
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C9ORF72-expansions and precipitate C9ORF72-ALS as opposed to
non-motor manifestations of C9ORF72-disease such as frontotempo-
ral dementia (FTD). Consistent with this, we have shown that
C9ORF72 gene expression is down-regulated during exercise, which
could act synergistically with haploinsufficiency caused by the G4C2-
repeat expansion, so enhancing neurotoxicity [68,69]. Secondly we
have shown that age of onset in C9ORF72-ALS is significantly corre-
lated with the ‘dose’ of historical physical activity; a similar but
weaker trend is present in non-C9ORF72-ALS patients, perhaps
because of increased heterogeneity in this group. The fact that
historical physical activity is more homogeneous in C9ORF72-ALS
patients is consistent with our hypothesis that physical exercise has a
modifier effect in this group. Finally, our data suggest that there may
be a link between C9ORF72 penetrance and exercise which could lead
to lifestyle recommendations and potentially disease prevention. It is
possible that individuals with a pathogenic C9ORF72 expansion and a
low dose of historical physical activity are not asymptomatic but may
develop a different phenotype such as FTD. We were not able to
assess this possibility because we selected for patients with a pure
C9ORF72-ALS phenotype due to the difficulty in obtaining accurate
Fig. 4. Case-control study of C9ORF72-ALS suggests a gene-environment interaction with physical activity (PA).
(a) Historical PA measured by the validated HAPAQ questionnaire is inversely related to time to disease onset in C9ORF72-ALS. To aid interpretation curves were plotted after
dividing historical PA into three interval-bins of equal size; low PA: 20.8-49.8kJ/kg/day; medium PA: 49.8-78.7kJ/kg/day; high PA: 78.7-108kJ/kg/day. (b) Measured historical PA is
less variable in C9ORF72-ALS compared to non-C9ORF72-ALS patients and neurologically normal controls.
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historical physical activity in the context of significant cognitive
impairment.
It is interesting that a recent MR study failed to identify a causal
link between strenuous physical activity and sporadic ALS. This study
considered only the type of exercise which had been performed in
the previous four weeks, with no criteria for frequency or duration
[11]. Similarly we did not detect a causal link between non-strenuous
or infrequent physical activity and ALS. This observation of a rela-
tively strict frequency cut-off could be linked to a threshold effect for
penetrance; any measure of physical activity which included individ-
uals exercising at a rate below the threshold would be significantly
confounded and may mask an association. Crucially the SSOE mea-
sure used in the present MR study enabled us to capture only activity
which was both frequent and intense.
In conclusion, the current evidence supports a complex causal
relationship between physical exercise and ALS. However, it is clear
that, for the majority of individuals, the health benefits of a physically
active lifestyle markedly outweigh the risks. The key objective for
future research is to understand which individuals are at risk of
developing ALS if they exercise excessively and provide appropriate
lifestyle counselling. Our work goes some way towards developing
this aim and in particular, we propose that C9ORF72 penetrance may
be influenced by high levels of physical activity.
Contributors
PJS, JCK and THJ conceived and designed the study. THJ, NG, ADFB,
YCK, MPS, JCK and PJS were responsible for data acquisition. JCK, THJ,
NG and PJS have verified the underlying data. THJ, NG, ADFB, YCK,
MN, SZ, JCK and PJS were responsible for analysis of data. THJ, NG,
ADFB, TM, CH, YCK, MN, SZ, MPS, JCK and PJS were responsible for
interpretation of data. THJ, JCK and PJS prepared the manuscript with
assistance from all authors. All authors meet the four ICMJE author-
ship criteria, and were responsible for revising the manuscript,
approving the final version for publication, and for the accuracy and
integrity of the work.
Data sharing statement
Genome-wide association summary statistics are available and
linked from the original manuscripts (Methods). Rare variant burden
testing statistics are available through the Project MinE Data Browser
at http://databrowser.projectmine.com/ [43]. Transcriptome changes
in response to acute exercise are available from the original publica-
tion [44].
Declaration of Competing Interest
M.P.S. is a cofounder of Personalis, Qbio, Sensomics, Filtricine, Mir-
vie and January. He is on the scientific advisory board of these compa-
nies and Genapsys. No other authors have competing interests.
Acknowledgements
This work was supported by research grants from the National
Institutes of Health (CEGS 5P50HG00773504, 1P50HL083800,
1R01HL101388, 1R01-HL122939, S10OD025212, and P30DK116074,
UM1HG009442 to MPS) and the Wellcome Trust (216596/Z/19/Z to
JCK), a Kingsland Fellowship (TM), an NIHR Foundation Fellowship
(THJ) and an NIHR Senior Investigator Award (NF-SI-0617-10077 to
PJS). This work was also supported by the NIHR Sheffield Biomedical
Research Centre for Translational Neuroscience (IS-BRC-1215-
20017). We thank Dr Thomas Jenkins, Dr Channa Hewamadduma,
Professor Christopher McDermott, Professor Martin Turner and Pro-
fessor Kevin Talbot who referred ALS patients to our study. We are
very grateful to those ALS patients and control subjects who gener-
ously donated the biosamples underpinning this study.
Supplementary materials
Supplementary material associated with this article can be found,
in the online version, at doi:10.1016/j.ebiom.2021.103397.
References
[1] Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med
2017;377:162–72.
[2] Cooper-Knock J, Jenkins T, Shaw PJ. Clinical and molecular aspects of motor neu-
ron disease. Biota Publishing; 2013.
[3] Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of
amyotrophic lateral sclerosis. JAMA Neurol 2019 https://doi.org/. doi: 10.1001/
jamaneurol.2019.2044.
[4] Trabjerg BB, Garton FC, van Rheenen W, Fang F, Henderson RD, Mortensen PB,
et al. ALS in Danish Registries: Heritability and links to psychiatric and cardiovas-
cular disorders. Neurol Genet 2020;6:e398.
[5] Al-Chalabi A, Calvo A, Chio A, Colville S, Ellis CM, Hardiman O, et al. Analysis of
amyotrophic lateral sclerosis as a multistep process: a population-based model-
ling study. Lancet Neurol 2014;13:1108–13.
[6] Chio A, Mazzini L, D'Alfonso S, Corrado L, Canosa A, Moglia C, et al. The multistep
hypothesis of ALS revisited: the role of genetic mutations. Neurology 2018;91:
e635–42.
[7] Chio A, Calvo A, Dossena M, Ghiglione P, Mutani R, Mora G. ALS in Italian profes-
sional soccer players: the risk is still present and could be soccer-specific. Amyo-
troph Lateral Scler 2009;10:205–9.
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